Scientific publications

Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis

Mar 30, 2023 | Magazine: Hemasphere

Miguel A Canales  1 , Thomas A Buchholz  2 , Jaisson A P Bortolini  3 , Laura M Fogliatto  4 , Takayuki Ishikawa  5 , Koji Izutsu  6 , Antonio Salar  7 , Jeff P Sharman  8 , Dirk Klingbiel  9 , Sunny Pokala  9 , Ekaterina Vorozheikina  10 , Peter Trask  11 , Joana Parreira  9 , Kai Hübel  12


No abstract available

CITATION  Hemasphere. 2023 Mar 30;7(4):e860. doi: 10.1097/HS9.0000000000000860

Our authors